drugset / Trial / NCT00002233
A Study of a Combination of Four Drugs in Patients With Recent HIV Infection
Open-labelTreatment
Summary
The purpose of this study is to see if it is safe to give a combination of four anti-HIV drugs to patients recently infected with HIV who have never received anti-HIV treatment. The effects of this combination of drugs on the immune system and the level of HIV in the body are studied also. The four-drug combination includes lamivudine, abacavir, amprenavir, and indinavir.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | — | — |
| Subject | Amprenavir | Other / unclassified | — | — |
| Subject | INDINAVIR ANHYDROUS | Other / unclassified | — | — |
| Subject | Lamivudine | Other / unclassified | — | — |